Pathologic responses to neoadjuvant chemoimmunotherapy in primary limited‐stage small‐cell lung cancer

BACKGROUND: Immunotherapy has been proved to have a large effect on extensive‐stage small cell lung cancer, but the role of immunotherapy in limited‐stage small‐cell lung cancer (LS‐SCLC) is still unknown. METHODS: A retrospective study of six patients with LS‐SCLC who were treated with neoadjuvant...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Meng, Zhang, Ran, Qi, Li‐sha, Wang, Ya‐lei, Sun, Xiao‐xuan, You, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663685/
https://www.ncbi.nlm.nih.gov/pubmed/36208136
http://dx.doi.org/10.1111/1759-7714.14679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663685/
https://www.ncbi.nlm.nih.gov/pubmed/36208136
http://dx.doi.org/10.1111/1759-7714.14679

Ejemplares similares